Literature DB >> 15986599

Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome-encapsulated Leishmania donovani antigens.

Tuhina Mazumdar1, K Anam, N Ali.   

Abstract

In this study, we evaluate the effect of phospholipid on the adjuvanicity and protective efficacy of liposome vaccine carriers against visceral leishmaniasis (VL) in a hamster model. Liposomes prepared with distearyol derivative of L-alpha-phosphatidyl choline (DSPC) having liquid crystalline transition temperature (Tc) 54 C were as efficient as dipalmitoyl (DPPC) (Tc 41 C) and dimyristoyl (DMPC) (Tc 23 C) derivatives in their ability to entrap Leishmania donovani membrane antigens (LAg) and to potentiate strong antigen-specific antibody responses. However, whereas LAg in DPPC and DMPC liposomes stimulated inconsistent delayed type hypersensitivity (DTH) responses, strong DTH was observed with LAg in DSPC liposomes. The heightened adjuvant activity of DSPC liposomes corresponded with 95% protection, with almost no protectivity with LAg in DPPC and DMPC liposomes, 4 mo after challenge with L. donovani. These data demonstrate the superiority of DSPC liposomes for formulation of L. donovani vaccine. In addition, they demonstrate a correlation of humoral and cell-mediated immunity with protection against VL in hamsters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986599     DOI: 10.1645/GE-356R1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  15 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

Review 2.  Liposomal adjuvant development for leishmaniasis vaccines.

Authors:  Anis Askarizadeh; Mahmoud Reza Jaafari; Ali Khamesipour; Ali Badiee
Journal:  Ther Adv Vaccines       Date:  2017-11-15

3.  Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.

Authors:  Rajesh Ravindran; Sudipta Bhowmick; Amrita Das; Nahid Ali
Journal:  BMC Microbiol       Date:  2010-06-24       Impact factor: 3.605

4.  Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice.

Authors:  Ali Badiee; Mahmoud R Jaafari; Afshin Samiei; Dina Soroush; Ali Khamesipour
Journal:  Clin Vaccine Immunol       Date:  2008-01-30

5.  Adjuvants for Leishmania vaccines: from models to clinical application.

Authors:  Vanitha S Raman; Malcolm S Duthie; Christopher B Fox; Greg Matlashewski; Steven G Reed
Journal:  Front Immunol       Date:  2012-06-11       Impact factor: 7.561

Review 6.  Recent Advances in Subunit Vaccine Carriers.

Authors:  Abhishek Vartak; Steven J Sucheck
Journal:  Vaccines (Basel)       Date:  2016-04-19

Review 7.  Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.

Authors:  Luis O De Serrano; David J Burkhart
Journal:  J Nanobiotechnology       Date:  2017-11-17       Impact factor: 10.435

8.  The role of nanoliposome bilayer composition containing soluble leishmania antigen on maturation and activation of dendritic cells.

Authors:  Sara Shokooh Saremi; Maryam Shahryari; Razieh Ghoorchian; Hamed Eshaghian; Seyed Amir Jalali; Amin Reza Nikpoor; Mahmoud Reza Jafari; Ali Badiee
Journal:  Iran J Basic Med Sci       Date:  2018-05       Impact factor: 2.699

9.  Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model.

Authors:  Ensieh Golali; Mahmoud Reza Jaafari; Ali Khamesipour; Azam Abbasi; Zahra Saberi; Ali Badiee
Journal:  Iran J Basic Med Sci       Date:  2012-09       Impact factor: 2.699

Review 10.  Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.

Authors:  Signe Tandrup Schmidt; Camilla Foged; Karen Smith Korsholm; Thomas Rades; Dennis Christensen
Journal:  Pharmaceutics       Date:  2016-03-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.